Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

European Generic Medicines Association

This page shows the latest European Generic Medicines Association news and features for those working in and with pharma, biotech and healthcare.

Pharma wants review of EMA pharmacovigilance fees

Pharma wants review of EMA pharmacovigilance fees

The pharmaceutical industry has called on the European Medicines Agency (EMA) to re-assess the way it handles pharmacovigilance payments to make them more "balanced and transparent". ... A joint statement from EFPIA and the European Generic medicines

Latest news

  • European biosimilar market will be worth $4bn a year by 2017

    Plans from the European Medicines Agency (EMA) to update guidance on biosimilars should also be beneficial to the industry, with the regulator due to clarify the definition of a biosimilar product ... For some, such as director general of the European

  • Amgen-Watson to collaborate on cancer biosimilars

    Greg Perry of the European Generic medicines Association (EGA) told PMLiVE: "I think there has been an enormous lack of concern from the political establishment about manufacturing in Europe and we ... One initiative that may help to address some of

  • European pharma industry calls for 'robust' HTA framework

    European pharma industry calls for 'robust' HTA framework. Healthcare bodies including pharma association EFPIA seek a more transparent framework for health technology assessment. ... The call is featured in a joint paper produced by organisations

  • EGA announces new president

    EGA announces new president. The European Generic medicines Association has announced current executive board member Gudbjorg Edda Eggertsdottir as its new president. ... The European Generic medicines Association (EGA) has announced current executive

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Can biosimilars live up to the hype? Can biosimilars live up to the hype?

    Can biosimilars live up to the hype? Carol Lynch, chair of the European Generic Medicines Association, wants new biosimilars therapies to become routine. ... Carol Lynch, recently elected chair of the European Generic Medicines Association, believes it

  • Interview: Greg Perry, European Generic medicines Association Interview: Greg Perry, European Generic medicines Association

    Perry set up the European Generic medicines Association (EGA) in the early days of the generics industry. ... Biography. Greg Perry established the European Generic medicines Association (EGA) in 1993 and has been its full-time director general since 1999

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Greg Perry joins IFPMA as assistant director general Greg Perry joins IFPMA as assistant director general

    Greg Perry joins IFPMA as assistant director general. Will move to the global industry body from the Medicines Patent Pool. ... Prior to his time at the Medicines Patent Pool, which he joined in 2013, Perry spent 14 years as director general of the

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Quick links

Infographics

Multimedia